» Articles » PMID: 19761881

Systematic Evaluation of a Tissue-engineered Bone for Maxillary Sinus Augmentation in Large Animal Canine Model

Overview
Journal Bone
Date 2009 Sep 19
PMID 19761881
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

The objective of this study is to systematically evaluate the effects of a tissue-engineered bone complex for maxillary sinus augmentation in a canine model. Twelve sinus floor augmentation surgeries in 6 animals were performed bilaterally and randomly repaired with the following 3 groups of grafts: group A consisted of tissue-engineered osteoblasts/beta-TCP complex (n=4); group B consisted of beta-TCP alone (n=4); group C consisted of autogenous bone obtained from iliac crest as a positive control (n=4). All dogs had uneventful healings following the surgery. Sequential polychrome fluorescent labeling, maxillofacial CT, microhardness tests, as well as histological and histomorphometric analyses indicated that the tissue-engineered osteoblasts/beta-TCP complex dramatically promoted bone formation and mineralization and maximally maintained the height and volume of elevated maxillary sinus. By comparison, both control groups of beta-TCP or autologous iliac bone showed considerable resorption and replacement by fibrous or fatty tissue. We thus conclude that beta-TCP alone could barely maintain the height and volume of the elevated sinus floor, and that the transplantation of autogenous osteoblasts on beta-TCP could promote earlier bone formation and mineralization, maximally maintain height, volume and increase the compressive strength of augmented maxillary sinus. This tissue engineered bone complex might be a better alternative to autologous bone for the clinical edentulous maxillary sinus augmentation.

Citing Articles

Trends of regenerative tissue engineering for oral and maxillofacial reconstruction in veterinary medicine.

Purbantoro S, Taephatthanasagon T, Purwaningrum M, Hirankanokchot T, Peralta S, Fiani N Front Vet Sci. 2024; 11:1325559.

PMID: 38450027 PMC: 10915013. DOI: 10.3389/fvets.2024.1325559.


Structural insights into the binding of zoledronic acid with RANKL computational simulations.

Wang R, Zhang W, Ma H, Zou D, Zhang Z, Wang S Front Mol Biosci. 2022; 9:992473.

PMID: 36200071 PMC: 9527314. DOI: 10.3389/fmolb.2022.992473.


A Novel Bone Substitute Based on Recombinant Type I Collagen for Reconstruction of Alveolar Cleft.

Ito M, Toriumi T, Hiratsuka T, Imura H, Akiyama Y, Chimedtseren I Materials (Basel). 2021; 14(9).

PMID: 33946797 PMC: 8125289. DOI: 10.3390/ma14092306.


Extracellular vesicles derived from human dental pulp stem cells promote osteogenesis of adipose-derived stem cells via the MAPK pathway.

Jin Q, Li P, Yuan K, Zhao F, Zhu X, Zhang P J Tissue Eng. 2020; 11:2041731420975569.

PMID: 33312494 PMC: 7716067. DOI: 10.1177/2041731420975569.


Endothelial progenitor cells with stem cells enhance osteogenic efficacy.

Li Q, Yu T, Wang F, Liu X, Wang Z Am J Transl Res. 2020; 12(6):2409-2424.

PMID: 32655780 PMC: 7344071.